AI-based histologic measurement of NASH (AIM-NASH): A drug development tool for assessing clinical trial end points

Limitations of manual pathology may confound results of NASH clinical trials. Our aim was to develop an AI-based drug development tool (AIM-NASH) that reproducibly calculates NASH Clinical Research Network (CRN) scores.